Review

post library screening (MedChemExpress)

MedChemExpress is a verified supplier

MedChemExpress manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

MedChemExpress post library screening
Post Library Screening, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 155 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/screening+libraries/Ibrutinib/pmc13062270-47-0-9
Average 96 stars, based on 155 article reviews

post library screening - by Bioz Stars, 2026-09

96/100 stars

Images

Synthesized:

Article Title: BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis
Article Snippet: .. IHMT-15137 and IHMT-15138 were synthesized and characterized in-house; ibrutinib (CAS #936563-96-1), adriamycin (CAS #23214-92-8), cisplatin (CAS #15663-27-1), etoposide (CAS #33419-42-0), ulixertinib (CAS #869886-67-9), palbociclib (CAS #571190-30-2), MG132 (CAS #133407-82-6), chloroquine (CAS #54-05-7), and cycloheximide (CAS #66-81-9) were purchased from MedChemExpress (MCE, Monmouth Junction, NJ, USA). .. Paclitaxel (CAS #33069-62-4), vincristine sulfate (CAS #2068-78-2), daunorubicin hydrochloride (CAS #23541-50-6), carboplatin (CAS # 41575-94-4), 5-FU (CAS # 2155827-07-7), and mitoxantrone (CAS # 65271-80-9) were purchased from TargetMol (Shanghai, China).

other:

Article Title: Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy.
Article Snippet: ■ MATERIALS AND METHODS Reagents and Chemicals Ibrutinib and ibrutinib-yne (PF-06658607) were purchased from Merck, and ibrutinib-FL (PCI-33380) was purchased from MedChemExpress.

Article Title: Mechanism-based prediction of drug synergy via network controllability analysis of therapeutic pathways in intractable diseases
Article Snippet: Ibrutinib , MedChemExpress , Cat# HY-10997.

Library Screening:

Article Title: Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability
Article Snippet: .. Post library screening, ibrutinib was purchased separately [cat. #HY‐10997, MedChemExpress, NJ, USA (distributed by Focus Bioscience)], with stock solutions utilised for subsequent experiments. ..